Trade Mark Journal No.2026/038 18 September 2026

UK00004440619 4 September 2026 (9,10)

SPH2O

International priority date claimed: 28 July 2026 (United States of America) (50/018772)

Class 9: Software as a Medical Device (SaMD), recorded, for use as a medical instrument for monitoring, measuring, and analyzing physiological and health parameters; Software as a Medical Device (SaMD), downloadable, for use as a medical instrument for monitoring, measuring, and analyzing physiological and health parameter; Recorded medical software for monitoring, measuring, and analyzing physiological and health parameters; Downloadable software for monitoring, measuring, and analyzing physiological and health parameters; Downloadable software for setting, tracking and monitoring health, fitness, sleep, and wellness goals of users; Recorded software for monitoring, measuring, displaying, storing and transmitting biometric data in the field of monitoring a person's health, fitness, and physiological conditions; Downloadable software for monitoring, measuring, displaying, storing and transmitting biometric data in the field of monitoring a person's health, fitness, and physiological conditions; Recorded computer programs using artificial intelligence (AI) for use in software development and machine learning in the fields of medical technology and monitoring a person's health and physiological conditions; Downloadable computer programs using artificial intelligence (AI) for use in software development and machine learning in the fields of medical technology and monitoring a person's health and physiological conditions; Wearable activity trackers; Recorded software for setting, tracking and monitoring health, fitness, sleep, and wellness goals of users.
Class 10: Medical apparatus and instruments for monitoring , measuring, and analyzing health or physiological conditions, and recorded software for recording, analyzing, processing and transmitting data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring , measuring, and analyzing health or physiological conditions, and recorded software using artificial intelligence (AI) for recording, analyzing, processing and transmitting data, for use therewith, sold as a unit; Wearable monitors used to measure biometric data for medical use; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Sensors for medical use to be worn by a human to gather human biometric data and also including recorded software sold as a unit; Medical apparatus and instruments for monitoring, measuring , and analyzing health or physiological conditions.

Willow Laboratories, Inc.

Representative: Fieldfisher LLP